This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2004;364(9449):1935-6.

doi: 10.1016/S0140-6736(04)17468-0.

Stem-cell therapy: what dose should we use?

PMID: 15567002
DOI: 10.1016/S0140-6736(04)17468-0

Comment

Stem-cell therapy: what dose should we use?

Thomas Ng. Lancet. 2004.

. 2004;364(9449):1935-6.

doi: 10.1016/S0140-6736(04)17468-0.

Author

PMID: 15567002
DOI: 10.1016/S0140-6736(04)17468-0

No abstract available

PubMed Disclaimer

Comment on

Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.
Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H. Wollert KC, et al. Lancet. 2004 Jul 10-16;364(9429):141-8. doi: 10.1016/S0140-6736(04)16626-9. Lancet. 2004. PMID: 15246726 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information